Published on 18 Nov 2024 on Zacks · via Yahoo Finance
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
The FDA had issued a complete response letter (CRL) for the first sBLA seeking approval of Dupixent...
NASDAQ.SNY price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free